Back
Neurocrine Biosciences Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
123.96
Seasonality Move:
16.93%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight buying pressure.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.81 | Buy |
| 20-day SMA: | 117.81 | Buy |
| 50-day SMA: | 119.15 | Buy |
| 200-day SMA: | 134.51 | Sell |
| 8-day EMA: | 121.17 | Buy |
| 20-day EMA: | 119.15 | Buy |
| 50-day EMA: | 121.98 | Buy |
| 200-day EMA: | 128.49 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 62.95 | Buy |
| Chaikin Money Flow: | 495738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.03 - 120.55) | Buy |
| Bollinger Bands (100): | (117.75 - 145.33) | Sell |
Neurocrine Biosciences Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 125.30 while NBIX 8-day simple moving average is 120.81, which is a Buy signal.
- The stock price of NBIX is 125.30 while Neurocrine Biosciences 20-day SMA is 117.81, which makes it a Buy.
- Neurocrine Biosciences 50-day simple moving average is 119.15 while NBIX share price is 125.30, making it a Buy technically.
- NBIX stock price is 125.30 and Neurocrine Biosciences 200-day simple moving average is 134.51, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Buy
The current Neurocrine Biosciences [NBIX] share price is $125.30. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
12.69B
Price in USD:
125.30
Share Volume:
1.2M
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
103.63
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 125.30 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 125.30 while NBIX 8-day exponential moving average is 121.17, which is a Buy signal.
- The stock price of NBIX is 125.30 while Neurocrine Biosciences 20-day EMA is 119.15, which makes it a Buy.
- Neurocrine Biosciences 50-day exponential moving average is 121.98 while NBIX share price is 125.30, making it a Buy technically.
- NBIX stock price is 125.30 and Neurocrine Biosciences 200-day simple moving average is 128.49, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $1.11 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is 0.91, suggesting Neurocrine Biosciences is a Buy
- Neurocrine Biosciences Relative Strength Index (RSI) is 62.95, which suggest Neurocrine Biosciences is overbought
- The Bollinger Bands (25) for Neurocrine Biosciences is (113.03 - 120.55), which suggest Neurocrine Biosciences is a Sell
- The Bollinger Bands (100) for Neurocrine Biosciences is (117.75 - 145.33), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.